Impact News +++ Soleno gains as Betaville cites buyout interest (SeekingAlpha) +++ SOLENO Aktie +3,57%

TRANSMEDICS Aktie

>TRANSMEDICS Aktienkurs

111.9 EUR +1.6% (Tradegate)

Ask: 114 EUR / 300 Stück

Bid: 113.15 EUR / 150 Stück

Tagesumsatz: 120 Stück

Realtime Kurs von 8 bis 22 Uhr!

TRANSMEDICS Aktie über LYNX handeln

Intraday

1 Jahr

>TRANSMEDICS Performance

1 Woche: -10,6%

1 Monat: -0,5%

3 Monate: +69,5%

6 Monate: +81,3%

1 Jahr: -16,1%

laufendes Jahr: +87,0%

>TRANSMEDICS Aktie

Name:

TRANSMEDICS GROUP

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US89377M1099 / A2PH5P

Symbol/ Ticker:

8T8 (Frankfurt) / TMDX (NASDAQ)

Kürzel:

FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX

Index:

Webseite:

https://www.transmedics.c..

Marktkapitalisierung:

4170 Mio. EUR

Umsatz:

131.05 Mio. EUR

EBITDA:

-9.07 Mio. EUR

Gewinn je Aktie:

-0.451 EUR

Schulden:

446.72 Mio. EUR

Liquide Mittel:

505.01 Mio. EUR

Umsatz-/ Gewinnwachstum:

155.7% / 110.6%

KGV/ KGV lG:

97.98 / 75.19

KUV/ KBV/ PEG:

10.41 / 17.68 / -

Gewinnm./ Eigenkapitalr.:

-11.77% / -18.13%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 728.153 USD.

Suchwörter:

TRANSMEDICS

Letzte Datenerhebung:

24.06.25

>TRANSMEDICS Eigentümer

Aktien: -

f.h. Aktien: 31.5 Mio. St.

Insider Eigner: 3.55%

Instit. Eigner: 94.47%

Leerverk. Aktien: 24.08%

>TRANSMEDICS Peer Group

BRUKER

EXELIXIS

GENMAB ADR

IMMUNIC

INSULET

IOVANCE

LIQUIDIA

MEDPACE

VANDA

VAXCYTE

>TRANSMEDICS Chart & Kurs - NASDAQ

>TRANSMEDICS News

14.06.25 - 01:15	Price Over Earnings Overview: TransMedics Group (Benzinga)
	read more...

11.06.25 - 01:02	Insiderhandel: Vorstand verkauft Aktien von TransMedics Group im Wert von 95903 USD (Insiderkauf)
	Ranganath, Anil P. - Vorstand - Tag der Transaktion: 2025-06-09...

02.06.25 - 17:30	TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
	When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?...

30.05.25 - 01:01	Insiderhandel: Aufsichtsrat verkauft Aktien von TransMedics Group im Wert von 632250 USD (Insiderkauf)
	Basile, Edward M. - Aufsichtsrat - Tag der Transaktion: 2025-05-27...

28.05.25 - 02:33	Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm (PR Newswire)
	NEW YORK, May 27, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of TransMedics Group, Inc. (NASDAQ: TMDX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders......

27.05.25 - 22:09	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
	ANDOVER, Mass., May 27, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 21, 2025, TransMedics......

24.05.25 - 03:01	Insiderhandel: Aufsichtsrat verkauft Aktien von TransMedics Group im Wert von 90680 USD (Insiderkauf)
	Weill, David - Aufsichtsrat - Tag der Transaktion: 2025-05-23...

23.05.25 - 18:15	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
	TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program....

20.05.25 - 22:06	TransMedics to Present at Upcoming June Investor Conferences (PR Newswire)
	ANDOVER, Mass., May 20, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in......

15.05.25 - 19:45	Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy? (Zacks)
	TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions....

15.05.25 - 19:45	What Makes TransMedics (TMDX) a New Buy Stock (Zacks)
	TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

14.05.25 - 03:01	Insiderhandel: Aufsichtsrat verkauft Aktien von TransMedics Group im Wert von 693780 USD (Insiderkauf)
	Basile, Edward M. - Aufsichtsrat - Tag der Transaktion: 2025-05-09...

13.05.25 - 11:48	TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher? (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 19:45	TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down (Zacks)
	Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance....

09.05.25 - 19:12	Why TransMedics Stock Is Skyrocketing Today (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 04:45	Transmedics raises 2025 revenue guidance to $565M-$585M with 28%-32% growth driven by OCS adoption (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 02:30	Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics (Zacks)
	The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

08.05.25 - 22:15	TransMedics Group GAAP EPS of $0.70 beats by $0.45, revenue of $143.5M beats by $20.11M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.25 - 22:06	TransMedics Reports First Quarter 2025 Financial Results (PR Newswire)
	ANDOVER, Mass., May 8, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended......

24.04.25 - 22:06	TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
	ANDOVER, Mass., April 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram